SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001516551-24-000114
Filing Date
2024-11-19
Accepted
2024-11-19 21:14:59
Documents
1
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1732068893.html 4  
1 FORM 4 wk-form4_1732068893.xml 4 5206
  Complete submission text file 0001516551-24-000114.txt   6941
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Grayson Paul A. (Reporting) CIK: 0001861554 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42009 | Film No.: 241478003